Dr Swaminathan Rathnakumar, MD | |
947 Old York Rd, Abington, PA 19001-4611 | |
(215) 886-3000 | |
Not Available |
Full Name | Dr Swaminathan Rathnakumar |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 947 Old York Rd, Abington, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205181070 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | MD038570-L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Swaminathan Rathnakumar, MD 947 Old York Rd, Abington, PA 19001-4611 Ph: () - | Dr Swaminathan Rathnakumar, MD 947 Old York Rd, Abington, PA 19001-4611 Ph: (215) 886-3000 |
News Archive
Despite living in the countryside, where open space is plentiful and there is often significant agricultural production, California's more than half a million rural elders are far more likely to be overweight or obese, physically inactive and food insecure than their suburban counterparts, according to a new policy brief from the UCLA Center for Health Policy Research.
The investigation into social networks by the University's Research Centre for Socio-Cultural Change found that men are more fickle and calculating about who they should be friends with.
The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that 403 of the nearly 900 proposals submitted are still in contention for CPRIT's inaugural cancer research funding awards. The applications for the Individual Investigator Research Award and the High Impact/High Risk Research Award will now undergo a second, more intense peer review evaluation by seven committees over the next six weeks beginning the end of this month.
The tangled highway of blood vessels that twists and turns inside our bodies, delivering essential nutrients and disposing of hazardous waste to keep our organs working properly has been a conundrum for scientists trying to make artificial vessels from scratch.
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
› Verified 5 days ago
Dr. Robert C Schmutzler Iii, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1245 Highland Ave, Suite 600, Abington, PA 19001 Phone: 215-886-1020 Fax: 215-887-1140 |